Treprostinil is under clinical development by United Therapeutics and currently in Phase III for Idiopathic Pulmonary Fibrosis.

Ralinepag XR is under clinical development by United Therapeutics and currently in Phase III for Pulmonary Arterial Hypertension.

At initiation of parenteral prostacyclin therapy, 62% of patients had intermediate-high COMPERA 2.0 risk status, whereas at ...

As the global economy recovers in 2021 and the supply of the industrial chain improves, the Pulmonary Arterial Hypertension (PAH) market will undergo major changes. According to the latest research, ...

A new study suggests that acetaminophen, also known as Tylenol, can cause complications in some people over age 65. Drs. Marc ...

Future Cardiol. 2013;9(3):335-349. Research into prostacyclin analogs for the treatment of WHO Group 2 PH has been limited, likely due to the early termination of the FIRST trial. [55] This study ...

Aurlumyn™ is a prostacyclin mimetic and acts as a vasodilator (a drug that opens blood vessels) and inhibits platelet aggregation. Aurlumyn™ is indicated for the treatment of severe frostbite in ...

So despite decades of frostbite injuries, until the advent of iloprost, options remained limited. Iloprost is a lab-made version of a natural compound in our bodies called prostacyclin. Prostacyclin ...

drugs such as prostacyclin analogues and calcium channel blockers might also be effective in slowing progression of the condition The patient initially received amlodipine, local debridement, and ...